Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00282087 · OUTCOME

Correlation Between 1988 FIGO Stage and Tumor Response to Treatment (PFS)

Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma · Source last updated 2014-12-01

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
participants
Interval / dispersion
Not reported
Time frame
2 years

What was measured

Stage I: confined to the uterine corpus Stage II: confined to corpus and cervix Stage IIIA: serosa involvement only (disease could involve the uterine serosa, but patients must have had no other evidence of local spread)

Groups in this outcome

Women Treated With Adjuvant Regimen for High Risk Uterine LMS

Not reported

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Women Treated With Adjuvant Regimen for High Risk Uterine LMS47

Reported measurements

FIFO Stage I
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Women Treated With Adjuvant Regimen for High Risk Uterine LMS38Not reportedNot reportedNot reportedNot reported
FIGO Stage II
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Women Treated With Adjuvant Regimen for High Risk Uterine LMS7Not reportedNot reportedNot reportedNot reported
FIGO Stage III
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Women Treated With Adjuvant Regimen for High Risk Uterine LMS2Not reportedNot reportedNot reportedNot reported

Source statistical analyses

Group order, estimate direction, methods and comments are retained. No treatment ranking is inferred.

  1. ci Num Sides
    TWO_SIDED
    group Description
    1988 FIGO Stage correlation with progression-free survival for patients on study treatment.
    group Ids
    1. OG000
    non Inferiority Type
    SUPERIORITY_OR_OTHER
    param Type
    Hazard Ratio (HR)
    param Value
    0.207
    statistical Method
    Cox Proportional Hazards
    tested Non Inferiority
    false
Complete source fields
analyses
  1. ci Num Sides
    TWO_SIDED
    group Description
    1988 FIGO Stage correlation with progression-free survival for patients on study treatment.
    group Ids
    1. OG000
    non Inferiority Type
    SUPERIORITY_OR_OTHER
    param Type
    Hazard Ratio (HR)
    param Value
    0.207
    statistical Method
    Cox Proportional Hazards
    tested Non Inferiority
    false
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        38
    title
    FIFO Stage I
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        7
    title
    FIGO Stage II
  3. categories
    1. measurements
      1. group Id
        OG000
        value
        2
    title
    FIGO Stage III
denoms
  1. counts
    1. group Id
      OG000
      value
      47
    units
    Participants
description
Stage I: confined to the uterine corpus Stage II: confined to corpus and cervix Stage IIIA: serosa involvement only (disease could involve the uterine serosa, but patients must have had no other evidence of local spread)
groups
  1. id
    OG000
    title
    Women Treated With Adjuvant Regimen for High Risk Uterine LMS
param Type
NUMBER
reporting Status
POSTED
time Frame
2 years
title
Correlation Between 1988 FIGO Stage and Tumor Response to Treatment (PFS)
type
SECONDARY
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice